Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. B. Koopman

Publications

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

95P Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

Clinical decision-making strategies for rare somatic variants in cancer

Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort

Molecular markers - PI3K / PIK3CA

Proof of concepts for automated extraction of mutation status from narrative pathology reports: KRAS G12C mutations and NTRK fusions in non-squamous non-small cell lung cancer

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses

Association of homozygous variants of STING1 with outcome in human cervical cancer

Detection of on-target ALK inhibitor resistance mutations and treatment options for patients with non-small cell lung cancer

Read more

Press/media

Breed testen en anticiperen op nieuwe behandelmogelijkheden

Moleculaire Tumor Boards

Interview by ZonMw

Interview for magazine "Longkanker"

Read more